nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—ERBB4—Disease—CDKN2B—ocular cancer	0.000352	0.000352	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—HRAS—ocular cancer	0.000349	0.000349	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—MDM2—ocular cancer	0.000349	0.000349	CbGpPWpGaD
Lapatinib—EGFR—PI3K/AKT activation—AKT1—ocular cancer	0.000348	0.000348	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000346	0.000346	CbGpPWpGaD
Lapatinib—EGFR—GAB1 signalosome—AKT1—ocular cancer	0.000345	0.000345	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—CDKN1A—ocular cancer	0.000342	0.000342	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SAG—ocular cancer	0.000339	0.000339	CbGpPWpGaD
Lapatinib—EGFR—ErbB1 downstream signaling—AKT1—ocular cancer	0.000338	0.000338	CbGpPWpGaD
Lapatinib—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—ocular cancer	0.000338	0.000338	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—CDKN1B—ocular cancer	0.000337	0.000337	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—EP300—ocular cancer	0.000335	0.000335	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—MYC—ocular cancer	0.000334	0.000334	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TGFB1—ocular cancer	0.000333	0.000333	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—GNA11—ocular cancer	0.000333	0.000333	CbGpPWpGaD
Lapatinib—EGFR—Disease—TFDP1—ocular cancer	0.000332	0.000332	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—CDKN1B—ocular cancer	0.000332	0.000332	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—GNA11—ocular cancer	0.000328	0.000328	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—EP300—ocular cancer	0.000327	0.000327	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—CDKN1B—ocular cancer	0.000323	0.000323	CbGpPWpGaD
Lapatinib—ERBB2—Axon guidance—HRAS—ocular cancer	0.000321	0.000321	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—CDKN1B—ocular cancer	0.000318	0.000318	CbGpPWpGaD
Lapatinib—EGFR—Direct p53 effectors—TP53—ocular cancer	0.000318	0.000318	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PSPH—ocular cancer	0.000317	0.000317	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—EP300—ocular cancer	0.000316	0.000316	CbGpPWpGaD
Lapatinib—TAP1—Immune System—HRAS—ocular cancer	0.000314	0.000314	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—AKT1—ocular cancer	0.000313	0.000313	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—MDM2—ocular cancer	0.000313	0.000313	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000311	0.000311	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—CDKN1A—ocular cancer	0.000311	0.000311	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—GNAQ—ocular cancer	0.00031	0.00031	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PSPH—ocular cancer	0.000309	0.000309	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—AKT1—ocular cancer	0.000309	0.000309	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—TGFB1—ocular cancer	0.000308	0.000308	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—CDKN1A—ocular cancer	0.000306	0.000306	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—GNAQ—ocular cancer	0.000305	0.000305	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—HRAS—ocular cancer	0.000302	0.000302	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000302	0.000302	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000301	0.000301	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—E2F5—ocular cancer	0.0003	0.0003	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.000299	0.000299	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—CDKN1A—ocular cancer	0.000298	0.000298	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—EP300—ocular cancer	0.000296	0.000296	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—E2F4—ocular cancer	0.000294	0.000294	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000294	0.000294	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—CDKN1A—ocular cancer	0.000294	0.000294	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—EP300—ocular cancer	0.000291	0.000291	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—TGFB1—ocular cancer	0.000291	0.000291	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—HRAS—ocular cancer	0.000289	0.000289	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—RBL1—ocular cancer	0.000288	0.000288	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—CDKN1B—ocular cancer	0.000285	0.000285	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—HRAS—ocular cancer	0.000284	0.000284	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—HDAC1—ocular cancer	0.000279	0.000279	CbGpPWpGaD
Lapatinib—TAP1—Immune System—AKT1—ocular cancer	0.000277	0.000277	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—HDAC1—ocular cancer	0.000275	0.000275	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TP53—ocular cancer	0.000274	0.000274	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—GNA11—ocular cancer	0.000273	0.000273	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—CDK4—ocular cancer	0.000272	0.000272	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—HRAS—ocular cancer	0.000272	0.000272	CbGpPWpGaD
Lapatinib—EGFR—EGF/EGFR Signaling Pathway—HRAS—ocular cancer	0.00027	0.00027	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—HRAS—ocular cancer	0.00027	0.00027	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—HRAS—ocular cancer	0.000269	0.000269	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—HRAS—ocular cancer	0.000268	0.000268	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—AKT1—ocular cancer	0.000267	0.000267	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—ocular cancer	0.000264	0.000264	CbGpPWpGaD
Lapatinib—EGFR—Disease—MAML2—ocular cancer	0.000264	0.000264	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—CDKN1A—ocular cancer	0.000263	0.000263	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—AKT1—ocular cancer	0.000255	0.000255	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—GNAQ—ocular cancer	0.000254	0.000254	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.000252	0.000252	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—HRAS—ocular cancer	0.000252	0.000252	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—HRAS—ocular cancer	0.000252	0.000252	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—HRAS—ocular cancer	0.000252	0.000252	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—AKT1—ocular cancer	0.000251	0.000251	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CDKN2B—ocular cancer	0.00025	0.00025	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—E2F3—ocular cancer	0.00025	0.00025	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—HRAS—ocular cancer	0.00025	0.00025	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000248	0.000248	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—HRAS—ocular cancer	0.000247	0.000247	CbGpPWpGaD
Lapatinib—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.000247	0.000247	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CDKN2B—ocular cancer	0.000247	0.000247	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—HRAS—ocular cancer	0.000246	0.000246	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—AKT1—ocular cancer	0.00024	0.00024	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—AKT1—ocular cancer	0.000239	0.000239	CbGpPWpGaD
Lapatinib—EGFR—EGF/EGFR Signaling Pathway—AKT1—ocular cancer	0.000239	0.000239	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—HRAS—ocular cancer	0.000238	0.000238	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—AKT1—ocular cancer	0.000237	0.000237	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—AKT1—ocular cancer	0.000236	0.000236	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—HRAS—ocular cancer	0.000233	0.000233	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—AKT1—ocular cancer	0.000233	0.000233	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TFDP1—ocular cancer	0.000232	0.000232	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—AKT1—ocular cancer	0.000232	0.000232	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—E2F1—ocular cancer	0.00023	0.00023	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—HRAS—ocular cancer	0.000229	0.000229	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—E2F1—ocular cancer	0.000226	0.000226	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—ocular cancer	0.000223	0.000223	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—AKT1—ocular cancer	0.000222	0.000222	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—AKT1—ocular cancer	0.000222	0.000222	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—AKT1—ocular cancer	0.000222	0.000222	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—AKT1—ocular cancer	0.00022	0.00022	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—AKT1—ocular cancer	0.000218	0.000218	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000218	0.000218	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—AKT1—ocular cancer	0.000217	0.000217	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	0.000215	0.000215	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—MDM2—ocular cancer	0.000215	0.000215	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—MDM2—ocular cancer	0.000212	0.000212	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—AKT1—ocular cancer	0.00021	0.00021	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000209	0.000209	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—AKT1—ocular cancer	0.000206	0.000206	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—HRAS—ocular cancer	0.000202	0.000202	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—AKT1—ocular cancer	0.000202	0.000202	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—HRAS—ocular cancer	0.000199	0.000199	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000199	0.000199	CbGpPWpGaD
Lapatinib—ERBB2—Disease—MDM2—ocular cancer	0.000198	0.000198	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—AKT1—ocular cancer	0.000198	0.000198	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—AKT1—ocular cancer	0.000197	0.000197	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CDKN1B—ocular cancer	0.000196	0.000196	CbGpPWpGaD
Lapatinib—ERBB4—Disease—MDM2—ocular cancer	0.000195	0.000195	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—HRAS—ocular cancer	0.000194	0.000194	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CDKN1B—ocular cancer	0.000193	0.000193	CbGpPWpGaD
Lapatinib—EGFR—Disease—HDAC1—ocular cancer	0.000193	0.000193	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—HRAS—ocular cancer	0.000191	0.000191	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—AKT1—ocular cancer	0.000191	0.000191	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PSPH—ocular cancer	0.00019	0.00019	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.00019	0.00019	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MAML2—ocular cancer	0.000185	0.000185	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000184	0.000184	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CDKN1B—ocular cancer	0.000181	0.000181	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CDKN1A—ocular cancer	0.000181	0.000181	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—AKT1—ocular cancer	0.000179	0.000179	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CDKN1B—ocular cancer	0.000178	0.000178	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—MDM2—ocular cancer	0.000178	0.000178	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CDKN1A—ocular cancer	0.000178	0.000178	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—AKT1—ocular cancer	0.000176	0.000176	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000175	0.000175	CbGpPWpGaD
Lapatinib—EGFR—Disease—CDKN2B—ocular cancer	0.000173	0.000173	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—EP300—ocular cancer	0.000172	0.000172	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—AKT1—ocular cancer	0.000172	0.000172	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—HRAS—ocular cancer	0.000172	0.000172	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—MDM2—ocular cancer	0.000171	0.000171	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—EP300—ocular cancer	0.00017	0.00017	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—AKT1—ocular cancer	0.000169	0.000169	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CDKN1A—ocular cancer	0.000167	0.000167	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CDKN1A—ocular cancer	0.000165	0.000165	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CDKN1B—ocular cancer	0.000163	0.000163	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—EP300—ocular cancer	0.000162	0.000162	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—GNA11—ocular cancer	0.000161	0.000161	CbGpPWpGaD
Lapatinib—ERBB2—Disease—EP300—ocular cancer	0.000159	0.000159	CbGpPWpGaD
Lapatinib—ERBB4—Disease—EP300—ocular cancer	0.000157	0.000157	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CDKN1B—ocular cancer	0.000156	0.000156	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—HRAS—ocular cancer	0.000155	0.000155	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000152	0.000152	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000152	0.000152	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—AKT1—ocular cancer	0.000151	0.000151	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CDKN1A—ocular cancer	0.00015	0.00015	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—GNAQ—ocular cancer	0.00015	0.00015	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CDKN1A—ocular cancer	0.000144	0.000144	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—EP300—ocular cancer	0.000143	0.000143	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TGFB1—ocular cancer	0.000141	0.000141	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MDM2—ocular cancer	0.000139	0.000139	CbGpPWpGaD
Lapatinib—ERBB2—Disease—MYC—ocular cancer	0.000139	0.000139	CbGpPWpGaD
Lapatinib—ERBB2—Disease—TGFB1—ocular cancer	0.000138	0.000138	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MDM2—ocular cancer	0.000137	0.000137	CbGpPWpGaD
Lapatinib—ERBB4—Disease—MYC—ocular cancer	0.000136	0.000136	CbGpPWpGaD
Lapatinib—ERBB4—Disease—TGFB1—ocular cancer	0.000136	0.000136	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HDAC1—ocular cancer	0.000135	0.000135	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GNA11—ocular cancer	0.000129	0.000129	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CDKN1B—ocular cancer	0.000127	0.000127	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000125	0.000125	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CDKN1B—ocular cancer	0.000125	0.000125	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CDKN2B—ocular cancer	0.000121	0.000121	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CCND1—ocular cancer	0.000121	0.000121	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GNAQ—ocular cancer	0.00012	0.00012	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CCND1—ocular cancer	0.000119	0.000119	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—HRAS—ocular cancer	0.000118	0.000118	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CDKN1A—ocular cancer	0.000117	0.000117	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—HRAS—ocular cancer	0.000116	0.000116	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CDKN1A—ocular cancer	0.000115	0.000115	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GNA11—ocular cancer	0.000112	0.000112	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—EP300—ocular cancer	0.000111	0.000111	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—E2F1—ocular cancer	0.000111	0.000111	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—HRAS—ocular cancer	0.000111	0.000111	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—EP300—ocular cancer	0.00011	0.00011	CbGpPWpGaD
Lapatinib—ERBB2—Disease—HRAS—ocular cancer	0.000109	0.000109	CbGpPWpGaD
Lapatinib—ERBB4—Disease—HRAS—ocular cancer	0.000107	0.000107	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000106	0.000106	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—AKT1—ocular cancer	0.000104	0.000104	CbGpPWpGaD
Lapatinib—EGFR—Immune System—MDM2—ocular cancer	0.000104	0.000104	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GNAQ—ocular cancer	0.000104	0.000104	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—AKT1—ocular cancer	0.000102	0.000102	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GNA11—ocular cancer	9.96e-05	9.96e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—HRAS—ocular cancer	9.78e-05	9.78e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—AKT1—ocular cancer	9.78e-05	9.78e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GNA11—ocular cancer	9.72e-05	9.72e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MYC—ocular cancer	9.7e-05	9.7e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TGFB1—ocular cancer	9.68e-05	9.68e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—AKT1—ocular cancer	9.61e-05	9.61e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—MDM2—ocular cancer	9.59e-05	9.59e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MYC—ocular cancer	9.56e-05	9.56e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TGFB1—ocular cancer	9.53e-05	9.53e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CDKN1B—ocular cancer	9.48e-05	9.48e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—AKT1—ocular cancer	9.46e-05	9.46e-05	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—HRAS—ocular cancer	9.39e-05	9.39e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GNAQ—ocular cancer	9.26e-05	9.26e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GNAQ—ocular cancer	9.04e-05	9.04e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CDKN1B—ocular cancer	8.75e-05	8.75e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CDKN1A—ocular cancer	8.75e-05	8.75e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—AKT1—ocular cancer	8.64e-05	8.64e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—ocular cancer	8.37e-05	8.37e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—EP300—ocular cancer	8.32e-05	8.32e-05	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—AKT1—ocular cancer	8.29e-05	8.29e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CDKN1A—ocular cancer	8.08e-05	8.08e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TP53—ocular cancer	7.97e-05	7.97e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TP53—ocular cancer	7.85e-05	7.85e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—EP300—ocular cancer	7.69e-05	7.69e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—HRAS—ocular cancer	7.62e-05	7.62e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—HRAS—ocular cancer	7.51e-05	7.51e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—EP300—ocular cancer	7.47e-05	7.47e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—AKT1—ocular cancer	6.73e-05	6.73e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MDM2—ocular cancer	6.71e-05	6.71e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—MYC—ocular cancer	6.7e-05	6.7e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—TGFB1—ocular cancer	6.68e-05	6.68e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—AKT1—ocular cancer	6.63e-05	6.63e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—HRAS—ocular cancer	6.24e-05	6.24e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CDKN1B—ocular cancer	6.13e-05	6.13e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GNA11—ocular cancer	5.99e-05	5.99e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCND1—ocular cancer	5.85e-05	5.85e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HRAS—ocular cancer	5.7e-05	5.7e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CDKN1A—ocular cancer	5.66e-05	5.66e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GNAQ—ocular cancer	5.57e-05	5.57e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—AKT1—ocular cancer	5.51e-05	5.51e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—EP300—ocular cancer	5.38e-05	5.38e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—HRAS—ocular cancer	5.26e-05	5.26e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—AKT1—ocular cancer	5.03e-05	5.03e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MYC—ocular cancer	4.69e-05	4.69e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TGFB1—ocular cancer	4.68e-05	4.68e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—AKT1—ocular cancer	4.64e-05	4.64e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—EP300—ocular cancer	4.31e-05	4.31e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TP53—ocular cancer	3.85e-05	3.85e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—EP300—ocular cancer	3.73e-05	3.73e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HRAS—ocular cancer	3.68e-05	3.68e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—EP300—ocular cancer	3.33e-05	3.33e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—AKT1—ocular cancer	3.25e-05	3.25e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—EP300—ocular cancer	3.25e-05	3.25e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—AKT1—ocular cancer	2.6e-05	2.6e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—AKT1—ocular cancer	2.25e-05	2.25e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—AKT1—ocular cancer	2.01e-05	2.01e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—EP300—ocular cancer	2e-05	2e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—AKT1—ocular cancer	1.96e-05	1.96e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—AKT1—ocular cancer	1.21e-05	1.21e-05	CbGpPWpGaD
